We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Reducing Barriers to 17-Hydroxprogestrone Caproate (17P) Injections to Prevent Recurrent Preterm Birth in Mississippi.
- Authors
BOFILL, JAMES A.; COLLIER, CHARLENE H.; PEARSON, MEG; SHWAYDER, JAMES M.; MORRISON, JOHN C.
- Abstract
The article discusses the challenges faced by Mississippi in its efforts to reduce and prevent the recurrent preterm birth of pregnant women including prioritization of 17-aplha hydroxy progesterone caproate (17P) in treatment for preterm labor. Topics include the iniatives to reduce 17P barriers including the treatment's coverage in all private insurance companies, the medication offered by Medicaid plans to selected women and the reduction of cost by company market AMAG Pharmaceuticals Inc.
- Subjects
PREMATURE labor; HYDROXYPROGESTERONE; CAPROATES; INSURANCE companies; AMAG Pharmaceuticals Inc.; THERAPEUTICS
- Publication
Journal of the Mississippi State Medical Association, 2016, Vol 58, Issue 11, p350
- ISSN
0026-6396
- Publication type
Article